Company intelligence / Profile preview

Lenstec

Saint Petersburg, Florida, United Stateslenstec.com ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

Lenstec has developed and commercialized a range of intraocular lenses (IOLs), including the FDA-approved Softec HD bi-aspheric and Softec I monofocal implants. Their products are marketed in over 60 countries and have been implanted in more than eight million patients worldwide. The company emphasizes precision manufacturing with quarter-diopter increments for improved patient outcomes.

Therapeutic areas: Ophthalmology
Modalities: DeviceImplantable medical deviceBiologic
Industry: Implantable Medical Devices

Drug pipeline

5 assets

ClearView 3

Commercial

Indications: Cataract, Presbyopia

4 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Lenstec.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lenstec.

Explore the full profile